Doxepin
Showing 1 - 25 of 32
Swallowing-induced Pain Trial in Guangzhou (doxepin solution, Placebo)
Not yet recruiting
- Swallowing-induced Pain
- doxepin solution
- Placebo
-
Guangzhou, Guangdong, ChinaSouthern medical university
Aug 24, 2023
Urticaria Trial in Syracuse (Doxepin, Diphenhydramine)
Recruiting
- Urticaria
- Doxepin
- Diphenhydramine
-
Syracuse, New YorkSUNY Upstate Medical University
May 17, 2022
Functional Gastrointestinal Disorders, Dyspepsia, Psychosomatic Disorder Trial in Shanghai (Zhizhu Kuanzhong capsules (ZZKZ),
Recruiting
- Functional Gastrointestinal Disorders
- +2 more
- Zhizhu Kuanzhong capsules (ZZKZ)
- Doxepin Hydrochloride (Doxepin)
-
Shanghai, Shanghai, ChinaRenji Hospital
Aug 8, 2022
Itch Trial in Aalborg (Doxepin Topical, Papain, Histamine)
Completed
- Itch
- Doxepin Topical
- +3 more
-
Aalborg, Nordjylland, DenmarkAalborg University
Jul 19, 2022
Bipolar Disorder Therapies
Completed
- Bipolar Disorder
- Lithium Carbonate
- +29 more
-
Albuquerque, New MexicoChristophe G Lambert
Sep 29, 2021
Esophageal Carcinoma, Hypopharyngeal Carcinoma, Laryngeal Carcinoma Trial in Rochester, Omaha, Green Bay (Doxepin Hydrochloride,
Terminated
- Esophageal Carcinoma
- +13 more
- Doxepin Hydrochloride
- +3 more
-
Rochester, Minnesota
- +2 more
Sep 10, 2019
Breast Cancer Trial in Isfahan (Doxepin cream 5%, Placebo)
Unknown status
- Breast Cancer
- Doxepin cream 5%
- Placebo
-
Isfahan, Iran, Islamic Republic ofIsfahan University of Medical Sciences
Jan 15, 2019
Itch Trial in Aalborg (Zyclara 3.75 % Topical Cream, Prudoxin, Histamine)
Withdrawn
- Itch
- Zyclara 3.75 % Topical Cream
- +5 more
-
Aalborg, Nordjylland, DenmarkAalborg University
Jan 13, 2021
Uremic Pruritus Trial in Beirut (Doxepin, Gabapentin)
Completed
- Uremic Pruritus
- Doxepin
- Gabapentin
-
Beirut, LebanonSaint George Hospital University Medical Center
Nov 28, 2018
Oral Mucositis Trial (Bocaliner, Benzydamine)
Enrolling by invitation
- Oral Mucositis
- Bocaliner
- Benzydamine
-
Yerevan, ArmeniaHematology Center after Prof. R. Yeolyan
Dec 20, 2022
Adverse Drug Reaction Trial in Worldwide (Pharmacogenomic testing)
Completed
- Adverse Drug Reaction
- Pharmacogenomic testing
-
Vienna, Austria
- +6 more
Apr 15, 2022
Oral Mucositis, Stem Cell Transplant Complications Trial in Yerevan (Bocaliner)
Not yet recruiting
- Oral Mucositis
- Stem Cell Transplant Complications
- Bocaliner
-
Yerevan, ArmeniaHematology Center after Prof. R. Yeolyan MH RA
Nov 21, 2021
Acute Oral Mucositis Pain Trial in United States (doxepin HCl oral solution, DLA (diphenhydramine, lidocaine and antacids)
Completed
- Acute Oral Mucositis Pain
- doxepin hydrochloride oral solution
- +2 more
-
Anchorage, Alaska
- +349 more
Oct 4, 2019
Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL
Completed
- Graft Vs Host Disease
- +2 more
- TREATMENT OF ORAL MUCOSITIS USING PLATELET-RICH-FIBRIN (PRF)
-
Taviano, ItalyFrancesco Gianfreda
Aug 18, 2021
Adverse Drug Reaction Trial in Indianapolis (Pharmacogenetic Intervention Arm (pharmacogenetic testing))
Completed
- Adverse Drug Reaction
- Pharmacogenetic Intervention Arm (pharmacogenetic testing)
-
Indianapolis, IndianaEskenazi Health System
Jan 6, 2021
Healthy Trial in Novi (Silenor 6 mg, zolpidem 10 mg, Placebo)
Completed
- Healthy
- Silenor 6 mg
- +2 more
-
Novi, MichiganHenry Ford Hospital Sleep Disorders & Research Center
Dec 6, 2017
Insomnia Trial in Novi (Suvorexant 10 mg, Suvorexant 20 mg, Placebo oral capsule)
Completed
- Insomnia
- Suvorexant 10 mg
- +2 more
-
Novi, MichiganHenry Ford Medical Center - Columbus
Oct 30, 2019
Head Neck Cancer, Mucositis, Oral Complications of Radiation Therapy Trial in United States (doxepin HCl, )
Completed
- Head and Neck Cancer
- +3 more
- doxepin hydrochloride
- placebo
-
Scottsdale, Arizona
- +119 more
Jul 11, 2017
Metastatic Cancer Trial in Hangzhou (Non Chemotherapy, Chemotherapy and target therapy, Chinese herb medicine)
Unknown status
- Metastatic Cancer
- Non Chemotherapy
- +2 more
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital, affiliated with Zhejiang University S
Feb 12, 2019
Nasopharyngeal Carcinoma Trial in Guangzhou (Controlled-release oxycodone, Chemoradiotherapy)
Unknown status
- Nasopharyngeal Carcinoma
- Controlled-release oxycodone
- Chemoradiotherapy
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 28, 2017
Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation Trial in United States
Completed
- Adverse Drug Events
- +12 more
-
Garden Grove, California
- +6 more
Feb 27, 2017
Parkinson's Disease, Insomnia Trial in Montreal (device, behavioral, drug)
Completed
- Parkinson's Disease
- Insomnia
- Light box (Litebook company)
- +3 more
-
Montreal, Quebec, CanadaMontreal General Hospital
Apr 15, 2015
Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)
Completed
- Atrial Fibrillation
- Marevan®
- +2 more
-
São Paulo, BrazilHospital São Paulo/Hospital Universitário da UNIFESP (University
Nov 21, 2016